FDA approves expanded use of Bristol Myers' cancer cell therapy

[cafead]

via The U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's (BMY.N) cancer cell therapy Breyanzi for the treatment of adults with a type of blood cancer called follicular lymphoma, that has returned or has not responded to prior treatments.

article source